{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/6530820c6520850012fa4d89?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Thursday, October 19, 2023","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1697677795787-ceba74beb51ca396067b6571b7a47e4a.jpeg?height=200","description":"<p>CMS has removed amyloid PET scan restrictions for Medicare beneficiaries.&nbsp;Novo Nordisk stops its Ozempic trial for treating kidney failure following early signs of the drug’s success. And, a new study finds that healthcare providers continue to leave the field in droves.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.</p><p><br></p>","author_name":"Gist Healthcare Daily"}